Showing results (201-210 of 216) with videos related to

Sort By:
Pageof 22
Environmental Toxicology and Chemistry|May 10, 2001
Effects of nonylphenol, bisphenol A, and their mixture on the viviparous swordtail fish (Xiphophorus helleri)H I Kwak, M O Bae, M H Lee, et al.
Oncogene|November 7, 2012
CpG island shore methylation regulates caveolin-1 expression in breast cancerX Rao, J Evans, H Chae, et al.
Science (New York, N.Y.)|February 5, 2021
Programmable hyperbolic polaritons in van der Waals semiconductorsA J Sternbach, S H Chae, S Latini, et al.
Anesthesia and Analgesia|December 15, 2018
Society of Cardiovascular Anesthesiologists/European Association of Cardiothoracic Anaesthetists Practice Advisory for the Management of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac SurgeryJ Daniel Muehlschlegel, Peter S Burrage, Jennie Yee Ngai, et al.
Journal of Cardiothoracic and Vascular Anesthesia|December 29, 2018
Society of Cardiovascular Anesthesiologists/European Association of Cardiothoracic Anaesthetists Practice Advisory for the Management of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac SurgeryBen O'Brien, Peter S Burrage, Jennie Yee Ngai, et al.
Nature Communications|July 5, 2020
Diamond Blackfan anemia is mediated by hyperactive Nemo-like kinaseM C Wilkes, K Siva, J Chen, et al.
Scientific Reports|May 19, 2018
Origin of magnetic properties in carbon implanted ZnO nanowiresY F Wang, Y C Shao, S H Hsieh, et al.
Physical Review Letters|October 9, 2002
Constraints on cosmological parameters from the analysis of the cosmic lens all sky survey radio-selected gravitational lens statisticsK-H Chae, A D Biggs, R D Blandford, et al.
ESMO Open|July 8, 2026
Phase II study of trastuzumab-pkrb plus gedatolisib in patients with HER2-positive metastatic breast cancer who progressed after two or more HER2-directed therapiesJ W Kim, Y H Park, S Lee, et al.
ESMO Open|September 25, 2025
Genomic and transcriptomic analyses of residual invasive triple-negative breast cancer after neoadjuvant chemotherapy in the prospective MIRINAE trial (a randomized phase II trial of adjuvant atezolizumab plus capecitabine compared to capecitabine; KCSG-BR18-21)S-A Im, K Park, J Koh, et al.
Pageof 22